Johnson & Johnson (BVL:JNJ)

Peru flag Peru · Delayed Price · Currency is PEN · Price in USD
190.00
0.00 (0.00%)
At close: Dec 4, 2025
18.75%
Market Cap 1.64T
Revenue (ttm) 322.36B
Net Income (ttm) 87.87B
Shares Out n/a
EPS (ttm) 36.20
PE Ratio 18.64
Forward PE 18.00
Dividend 18.28 (9.62%)
Ex-Dividend Date Nov 25, 2025
Volume n/a
Average Volume n/a
Open n/a
Previous Close 190.00
Day's Range n/a
52-Week Range 140.92 - 190.00
Beta n/a
RSI 96.23
Earnings Date Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange Lima Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.